The Dark Report and Siemens Introduce the World's First Integrated Molecu...(will have a choice of attending more tha...)

Date:1/28/2008

will have a choice of attending more than 26 educational sessions to learn how innovators are advancing clinical care and enhancing their financial strength by incorporating the latest molecular imaging techniques in tandem with emerging molecular diagnostics. Industry pioneers will speak about evolving changes in R&D, the discovery of new medicines, effective policies to translate these discoveries into better outcomes for patients, resulting treatments that improve healthcare, and new business strategies to advance the field of personalized medicine. Continuing Education Units (CEU's) are provided by the American Association of Clinical Chemistry (AACC).

"Healthcare is evolving, entering a new era, one created through the marriage of in vivo and in vitro diagnostics, arming clinicians with the tools that enable early intervention and treatment in a way that improves clinical efficiencies, effectiveness and outcomes," said Thomas Miller, CEO, Workflow and Solutions Division, Siemens Healthcare. "We are ushering in the era of personalized medicine, moving the practice of medicine from the disease- centric to the knowledge-driven, patient-centric approach. For all of us who care passionately about this -- pathologists, radiologists and healthcare IT executives -- the Summit will deliver the latest information defining the next generation of integrated diagnostic and clinical services."

The Molecular Summit will feature case studies involving the delivery of molecular imaging and molecular diagnostics services, particularly where collaboration is occurring between radiology, pathology, and informatics to integrate molecular imaging with relevant molecular diagnostics services.

"Alert physicians involved in imaging and molecular diagnostics know these technology advances are already breaking down traditional specialty silos," said Robert L. Michel, editor, The Dark Report. "The Molecular Summit brings together early adopters who will share their pr
'/>"/>

SOURCE Siemens Copyright©2008 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4
Related biology technology :

1. Varian, Inc. Reports First Quarter 2008 Results
2. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
3. Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis
4. VNUS Medical Technologies to Report Fourth-Quarter 2007 Results and Webcast Teleconference on February 7
5. Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results
6. Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues
7. Pharmasset Reports Fiscal Year End 2007 Financial Results
8. Avitar Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
10. Imagenetix Reports Results of Offer to Extend Warrants
11. Neurobiological Technologies, Inc. Reports Retirement of Ronald E. Cape, Ph.D., from Board